Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$94.38 -0.24 (-0.25%)
As of: Nov 12, 2026 · 11:36 AM EST

Mirum Pharmaceuticals (MIRM) Cash & Equivalents (2018 - 2026)

Updated

Mirum Pharmaceuticals' Cash & Equivalents was $243.19 million in Q3 2026, down 13.8% from $282.02 million a year earlier and down 26.5% from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Cash & Equivalents (2018 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at Mirum Pharmaceuticals came in at $296.68 million, up 33.1% from FY2024.

  • Cash & Equivalents shows a five-year compound annual growth rate of 15.9% (FY2020 to FY2025).
  • In earlier years, Cash & Equivalents was $222.93 million in FY2024 (-22.1%), $286.33 million in FY2023 (+123.7%), $128 million in FY2022 (-2.5%) and $131.34 million in FY2021 (-7.6%).
  • The Q3 2026 figure marks the lowest quarterly Cash & Equivalents since Q2 2025.
  • Compared with a year earlier, Cash & Equivalents was higher in four of the last eight quarters, with growth averaging 11.2%.
  • The best year-over-year quarter for Cash & Equivalents over five years was Q3 2023 (growth of 747.5%); the worst was Q1 2022 (a decline of 49.0%).
  • Per Business Quant data, MIRM's Cash & Equivalents in the three quarters before Q3 2026 was $330.73 million (Q2 2026), $324.91 million (Q1 2026) and $296.68 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 400.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.82 Bn
10 Mirum Pharmaceuticals 6.16 Bn 4.58 Bn 150.55 Mn 243.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 243.19 Mn
Jun 30, 2026 330.73 Mn
Mar 31, 2026 324.91 Mn
Dec 31, 2025 296.68 Mn
Sep 30, 2025 282.02 Mn
Jun 30, 2025 228.12 Mn
Mar 31, 2025 211.82 Mn
Dec 31, 2024 222.93 Mn
Sep 30, 2024 222.97 Mn
Jun 30, 2024 233.25 Mn
Mar 31, 2024 302.84 Mn
Dec 31, 2023 286.33 Mn
Sep 30, 2023 303.06 Mn
Jun 30, 2023 297.23 Mn
Mar 31, 2023 49.42 Mn
Dec 31, 2022 128.00 Mn
Sep 30, 2022 35.76 Mn
Jun 30, 2022 55.27 Mn
Mar 31, 2022 46.27 Mn
Dec 31, 2021 131.34 Mn
API Access

Mirum Pharmaceuticals Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MIRM&period=max&api_key=YOUR_API_KEY